Oura Health is preparing for a potential U.S. IPO that could raise up to $3 billion and value the sm

Hinge stock found support at a key level in recent weeks and is approaching multiple new buy points

Many people know that seemingly unrelated symptoms can be connected. But in most cases, treating ind

Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion int

HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support it

HNGE's rapid revenue growth, widening margins and higher 2026 outlook strengthen its case, but expan

HNGE's $105 million Cylinder deal opens a $135 billion GI care market, adding nearly 100 clients and

Hinge Health 64.6% three-month rally is backed by surging revenues, wider margins and a raised 2026

Investors need to pay close attention to HNGE stock based on the movements in the options market lat

On CNBC's “Mad Money Lightning Round,” Jim Cramer said Hinge Health, Inc. (NYSE:HNGE) is a buy. “Wha

Mad Money Lightning Round analysis: Hinge Health a buy after strong quarter, Stellantis not investib

Assenagon Asset Management S.A. bought a new stake in shares of Hinge Health Inc. (NYSE: HNGE) durin

Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raise

IVZ, HUBS, HNGE and PGNY make the cut as the top liquid stocks, each boasting strong liquidity, grow

Hinge Health Inc. (NYSE: HNGE - Get Free Report)'s share price shot up 9.5% on Wednesday following a

Hinge Health's Q2 revenues jump 53% as stronger member yield, margin gains and raised 2026 guidance

RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises

Citizens analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and rai

Wells Fargo analyst Stan Berenshteyn maintains Hinge Health (NYSE:HNGE) with a Overweight and rai

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperfor

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the

Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP

Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price

Hinge Health (NYSE: HNGE) reported second-quarter 2026 revenue of $213 million, up 53% from a year e

Hinge Health NYSE: HNGE reported second-quarter 2026 revenue of $213 million, up 53% from a year ear

Hinge Health, Inc. (HNGE) Q2 2026 Earnings Call Transcript

Hinge Health Inc. (HNGE) came out with quarterly earnings of $0.59 per share, in line with the Zacks

Hinge Health (NYSE:HNGE) raises FY2026 sales outlook from $818.000 million-$824.000 million to $856.

Hinge Health (NYSE:HNGE) reported quarterly earnings of $0.59 per share which met the analyst consen

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced that it has signed a

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results fo

Hinge Health, Inc. (NYSE: HNGE) announced today the publication of a new study that showed a signifi

Citizens analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and rai

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the

Keybanc analyst Scott Schoenhaus maintains Hinge Health (NYSE:HNGE) with a Overweight and raises

Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and

Wells Fargo analyst Stan Berenshteyn maintains Hinge Health (NYSE:HNGE) with a Overweight and rai

Baird analyst Vikram Kesavabhotla maintains Hinge Health (NYSE:HNGE) with a Neutral and raises th

Raymond James analyst Brian Peterson maintains Hinge Health (NYSE:HNGE) with a Outperform and rai

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises

Keybanc analyst Scott Schoenhaus maintains Hinge Health (NYSE:HNGE) with a Overweight and raises

RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises

Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raise

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the

Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price

Hinge Health, Inc. (NYSE:HNGE) announced today its full year 2026 revenue guidance raised to a range

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises

Oura Health is prepings its IPO, which will test whether public markets are ready for a new wave of

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises